Medtronic, Inc. (MDT) PT Lowered to $111 at Truist Securities
- Nasdaq closes lower as chipmaker Micron's warning renews tech rout
- Citi’s Top Equity Strategist Warns Analysts are Too Bullish on Stocks
- Bank of America Clients Continue to Buy the Rally, New Data Shows
- Novavax (NVAX) Crashes 30% After a Deep Guidance Cut, Analyst 'Frustrated'
- 'Hard to Say' Whether Current Crypto Bear Market is Over - Morgan Stanley
Truist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $111.00 (from $121.00) while maintaining a Hold rating.
You May Also Be Interested In
- BHP Billiton Ltd. (BHP:AU) (BHP) PT Raised to AUD36.55 at Morgan Stanley
- Beijing Kingsoft Office Software Inc (688111:CH) PT Raised to RMB210 at Morgan Stanley
- KG Inicis (035600:KS) PT Lowered to KRW13,000 at Goldman Sachs
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!